Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishanu Saha

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Nature Materials|August 24, 2010
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cellsYing Mei, Krishanu Saha, Said R Bogatyrev, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
The Journal of Clinical Investigation|August 10, 2023
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathyMeha Kabra, Pawan K Shahi, Yuyuan Wang, et al.
Science Advances|June 4, 2025
Low-dose radiation by radiopharmaceutical therapy enhances GD2 <i>TRAC</i>-CAR T cell efficacy in localized neuroblastomaQuaovi H Sodji, Amanda Shea, Dan Cappabianca, et al.
The CRISPR Journal|May 21, 2025
A Reset for Bioethics: A Statement from the Global Observatory for Genome EditingSheila Jasanoff, J Benjamin Hurlbut, Krishanu Saha, et al.
Cancers|January 11, 2024
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and FunctionsQuaovi H Sodji, Matthew H Forsberg, Dan Cappabianca, et al.
Nature Communications|January 4, 2019
CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavageJichao Sun, Jared Carlson-Stevermer, Utpal Das, et al.
American Journal of Human Genetics|July 25, 2020
Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant MaculopathyDivya Sinha, Benjamin Steyer, Pawan K Shahi, et al.
Elife|July 1, 2015
Strategies from UW-Madison for rescuing biomedical research in the USJudith Kimble, William M Bement, Qiang Chang, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Nature Materials|August 24, 2010
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cellsYing Mei, Krishanu Saha, Said R Bogatyrev, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
The Journal of Clinical Investigation|August 10, 2023
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathyMeha Kabra, Pawan K Shahi, Yuyuan Wang, et al.
Science Advances|June 4, 2025
Low-dose radiation by radiopharmaceutical therapy enhances GD2 <i>TRAC</i>-CAR T cell efficacy in localized neuroblastomaQuaovi H Sodji, Amanda Shea, Dan Cappabianca, et al.
The CRISPR Journal|May 21, 2025
A Reset for Bioethics: A Statement from the Global Observatory for Genome EditingSheila Jasanoff, J Benjamin Hurlbut, Krishanu Saha, et al.
Cancers|January 11, 2024
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and FunctionsQuaovi H Sodji, Matthew H Forsberg, Dan Cappabianca, et al.
Nature Communications|January 4, 2019
CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavageJichao Sun, Jared Carlson-Stevermer, Utpal Das, et al.
American Journal of Human Genetics|July 25, 2020
Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant MaculopathyDivya Sinha, Benjamin Steyer, Pawan K Shahi, et al.
Elife|July 1, 2015
Strategies from UW-Madison for rescuing biomedical research in the USJudith Kimble, William M Bement, Qiang Chang, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Pageof 10